Literature DB >> 22893074

Baseline traits of low vision patients served by private outpatient clinical centers in the United States.

Judith E Goldstein, Robert W Massof, James T Deremeik, Sonya Braudway, Mary Lou Jackson, K Bradley Kehler, Susan A Primo, Janet S Sunness.   

Abstract

OBJECTIVE: To characterize the traits of low vision patients who seek outpatient low vision rehabilitation (LVR) services in the United States.
METHODS: In a prospective observational study, we enrolled 764 new low vision patients seeking outpatient LVR services from 28 clinical centers in the United States. Before their initial appointment, multiple questionnaires assessing daily living and vision, physical, psychological, and cognitive health states were administered by telephone. Baseline clinical visual impairment measures and disorder diagnoses were recorded.
RESULTS: Patients had a median age of 77 years, were primarily female (66%), and had macular disease (55%), most of which was nonneovascular age-related macular degeneration. More than one-third of the patients (37%) had mild vision impairment with habitual visual acuity (VA) of 20/60 or greater. The VA correlated well with contrast sensitivity (r = -0.52) but poorly with self-reported vision quality. The intake survey revealed self-reported physical health limitations, including decreased endurance (68%) and mobility problems (52%). Many patients reported increased levels of frustration (42%) and depressed mood (22%); memory and cognitive impairment (11%) were less frequently endorsed. Patients relied on others for daily living support (87%), but many (31%) still drove.
CONCLUSIONS: Most patients seeking LVR are geriatric and have macular disease with relatively preserved VA. The disparity between VA and subjective quality of vision suggests that LVR referrals are based on symptoms rather than on VA alone. Patients seen for LVR services have significant physical, psychological, and cognitive disorders that can amplify vision disabilities and decrease rehabilitation potential.

Entities:  

Mesh:

Year:  2012        PMID: 22893074      PMCID: PMC6739234          DOI: 10.1001/archophthalmol.2012.1197

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  67 in total

1.  The relation between visual acuity and other spatial vision measures.

Authors:  G Haegerstrom-Portnoy; M E Schneck; L A Lott; J A Brabyn
Journal:  Optom Vis Sci       Date:  2000-12       Impact factor: 1.973

2.  A model of the prevalence and incidence of low vision and blindness among adults in the U.S.

Authors:  Robert W Massof
Journal:  Optom Vis Sci       Date:  2002-01       Impact factor: 1.973

3.  Health outcomes. New quality measure for Medicare.

Authors:  J K Cooper; T Kohlmann; J A Michael; S C Haffer; M Stevic
Journal:  Int J Qual Health Care       Date:  2001-02       Impact factor: 2.038

4.  Valuation of EuroQOL (EQ-5D) health states in an adult US sample.

Authors:  J A Johnson; S J Coons; A Ergo; G Szava-Kovats
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

Review 5.  Review of community prevalence of depression in later life.

Authors:  A T Beekman; J R Copeland; M J Prince
Journal:  Br J Psychiatry       Date:  1999-04       Impact factor: 9.319

6.  How does visual impairment affect performance on tasks of everyday life? The SEE Project. Salisbury Eye Evaluation.

Authors:  Sheila K West; Gary S Rubin; Aimee T Broman; Beatriz Muñoz; Karen Bandeen-Roche; Kathleen Turano
Journal:  Arch Ophthalmol       Date:  2002-06

7.  Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration.

Authors:  B L Brody; A C Gamst; R A Williams; A R Smith; P W Lau; D Dolnak; M H Rapaport; R M Kaplan; S I Brown
Journal:  Ophthalmology       Date:  2001-10       Impact factor: 12.079

8.  Visual impairment and risk of hip fracture.

Authors:  R Q Ivers; R Norton; R G Cumming; M Butler; A J Campbell
Journal:  Am J Epidemiol       Date:  2000-10-01       Impact factor: 4.897

9.  Effect of depression on vision function in age-related macular degeneration.

Authors:  Barry W Rovner; Robin J Casten; William S Tasman
Journal:  Arch Ophthalmol       Date:  2002-08

10.  The measurement of vision disability.

Authors:  Robert W Massof
Journal:  Optom Vis Sci       Date:  2002-08       Impact factor: 1.973

View more
  29 in total

1.  Telerehabilitation for people with low vision.

Authors:  Ava K Bittner; Stephanie L Wykstra; Patrick D Yoshinaga; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2014-03-10

2.  Telerehabilitation for people with low vision.

Authors:  Ava K Bittner; Patrick D Yoshinaga; Stephanie L Wykstra; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2020-02-27

Review 3.  Age-related psychophysical changes and low vision.

Authors:  Gislin Dagnelie
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-13       Impact factor: 4.799

4.  Association of Perceived Discrimination With Emotional Well-being in Older Adults With Visual Impairment.

Authors:  Sarah E Jackson; Ruth A Hackett; Shahina Pardhan; Lee Smith; Andrew Steptoe
Journal:  JAMA Ophthalmol       Date:  2019-07-01       Impact factor: 7.389

5.  Rehabilitation Referral for Patients With Irreversible Vision Impairment Seen in a Public Safety-Net Eye Clinic.

Authors:  M Austin Coker; Carrie E Huisingh; Gerald McGwin; Russell W Read; Mark W Swanson; Laura E Dreer; Dawn K DeCarlo; Lindsay Gregg; Cynthia Owsley
Journal:  JAMA Ophthalmol       Date:  2018-04-01       Impact factor: 7.389

Review 6.  Update on depression and age-related macular degeneration.

Authors:  Robin J Casten; Barry W Rovner
Journal:  Curr Opin Ophthalmol       Date:  2013-05       Impact factor: 3.761

7.  A low-vision rehabilitation program for patients with mild cognitive deficits.

Authors:  Heather E Whitson; Diane Whitaker; Guy Potter; Eleanor McConnell; Fay Tripp; Linda L Sanders; Kelly W Muir; Harvey J Cohen; Scott W Cousins
Journal:  JAMA Ophthalmol       Date:  2013-07       Impact factor: 7.389

Review 8.  Telerehabilitation for people with low vision.

Authors:  Ava K Bittner; Stephanie L Wykstra; Patrick D Yoshinaga; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2015-08-31

9.  Comparison of clinician-predicted to measured low vision outcomes.

Authors:  Tiffany L Chan; Judith E Goldstein; Robert W Massof
Journal:  Optom Vis Sci       Date:  2013-08       Impact factor: 1.973

10.  Topical application of a G-Quartet aptamer targeting nucleolin attenuates choroidal neovascularization in a model of age-related macular degeneration.

Authors:  Derek Leaderer; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  Exp Eye Res       Date:  2015-09-12       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.